Is GRP78 (Glucose-regulated protein 78) a prognostic biomarker in differents types of cancer? A systematic review and meta-analysis

NS Dos Santos, DR Gonçalves, B Balbinot… - Pathology-Research and …, 2023 - Elsevier
GRP78 is a chaperone with anti-apoptotic function associated with aggressive tumors. This
systematic review aimed to evaluate GRP78 expression in cancer and its relation to …

The future of ER+/HER2− metastatic breast cancer therapy: Beyond PI3K inhibitors

A Stravodimou, IA Voutsadakis - Anticancer Research, 2020 - ar.iiarjournals.org
Most breast cancers express the estrogen receptor (ER) receptor and are negative for the
human epidermal growth factor receptor 2 (HER2) receptor. ER+/HER2− cancers are treated …

The clinicopathological significance of BiP/GRP-78 in breast cancer: a meta-analysis of public datasets and immunohistochemical detection

I Direito, D Gomes, FL Monteiro, I Carneiro, J Lobo… - Current oncology, 2022 - mdpi.com
The endoplasmic reticulum chaperone BiP (also known as GRP-78 or HSPA5) maintains
protein folding to allow cell proliferation and survival and has been implicated in …

The anterior gradient homologue 2 (AGR2) co-localises with the glucose-regulated protein 78 (GRP78) in cancer stem cells, and is critical for the survival and drug …

D Hussein, R Alsereihi, AAA Salwati, R Algehani… - Cancer cell …, 2022 - Springer
Abstract Background Glioblastomas (GBs) are characterised as one of the most aggressive
primary central nervous system tumours (CNSTs). Single-cell sequencing analysis identified …

EGCG Enhances the Chemosensitivity of Colorectal Cancer to Irinotecan through GRP78‐MediatedEndoplasmic Reticulum Stress

W Wu, H Gou, B Xiang, R Geng, J Dong… - Journal of …, 2022 - Wiley Online Library
This study aimed to explore the role of GRP78‐mediated endoplasmic reticulum stress
(ERS) in the synergistic inhibition of colorectal cancer by epigallocatechin‐3‐gallate (EGCG) …

The Glucose-Regulated Protein78 (GRP78) in the unfolded protein response (UPR) pathway: a potential therapeutic target for breast cancer

MM Sadeghipour, SA Torabizadeh… - Anti-Cancer Agents in …, 2023 - ingentaconnect.com
Amongst all types of cancers, breast cancer is recognized as the most common cancer and a
principal cause of morbidity and mortality in women. Endoplasmic reticulum (ER) stress …

Chemotherapy-Induced Cell-Surface GRP78 Expression as a Prognostic Marker for Invasiveness of Metastatic Triple-Negative Breast Cancer

MB Alvarez-Elizondo, A Raiter, R Yerushalmi… - Annals of Biomedical …, 2025 - Springer
Metastasis remains the leading cause (90%) of cancer-related mortality, especially in
metastatic triple-negative breast cancer (TNBC). Improved understanding of molecular …

[HTML][HTML] Insights from the molecular docking analysis of GRP78 with natural compound inhibitors in the management of cancers

A Elaimi, MB Hanadi, A Almutairi, RA Alniwaider… - …, 2023 - ncbi.nlm.nih.gov
Cancer is regarded as one of the world's most serious health issues. Glucose regulated
protein (GRP78) exhibits a vital role in the proliferation, invasion, and metastasis of …

[HTML][HTML] BIK and GRP78 protein expression as possible markers of response to preoperative chemotherapy and survival in breast cancer

CDMT de Jesús, MGA Jaim, VVC Karina… - Taiwanese Journal of …, 2021 - Elsevier
Objective BIK and GRP78 have shown differential expression profiles in breast cancer (BC)
tissue, in addition to its important participation in the pathophysiology of cancer. The …

Managing Breast Cancer Using the Cell-Surface GRP78

AA Elfiky - 2024 - Springer
Breast cancer remains one of the leading causes of cancer-related deaths in women
worldwide. While significant advancements have been made in the treatment of breast …